What role does CYP2C19 play in blood sugar?

CYP2C19 is a cytochrome P450 enzyme primarily involved in the metabolism of drugs such as clopidogrel, proton pump inhibitors, and certain antidepressants. A direct role in blood sugar regulation is not established. Some studies suggest weak associations between CYP2C19 variants and type 2 diabetes risk or response to sulfonylureas, but effect sizes are small and not clinically actionable. The evidence is mostly mechanistic and pharmacogenetic, not reflecting direct glucose control. Consumer DNA tests typically include CYP2C19 for drug response, not blood sugar. Relying on genetics alone for blood sugar management is not supported; standard biomarkers (fasting glucose, HbA1c) and medical guidance are essential.